Shanghai, China The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Biopharma, Medical. Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Yaoshibang, Check-Cap. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
We also calculated 14 valuable employees in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fosun Pharma, startups are often financed by UFG Private Equity, Simul Investments, Pittsburgh Life Sciences Greenhouse. The meaningful sponsors for the fund in investment in the same round are South Valley Angels, Pontifax, Ohio Innovation Fund. In the next rounds fund is usually obtained by Green Pine Capital Partners, DCM Ventures, Yijing Capital.
Related Funds
| Fund Name | Location |
| Boat Rocker Ventures | California, Santa Monica, United States |
| Boston Impact Initiative | Jamaica Plain, Massachusetts, United States |
| Chipotle Mexican Grill | Colorado, Denver, United States |
| CITIC Guoan Group Corporation | Beijing, Beijing, China |
| Ericsson-Deutsche Technology Fund | Australia, New South Wales, Sydney |
| Harwick Overseas | - |
| iGlobe Partners | Central, Central Region, Singapore |
| Inheritance Enterprises | Central, Central Region, Singapore |
| Minmetals Capital | Beijing, China, Haidian |
| Ningbo Meishan Baoshui Gangqu Saiyi Boying Touzi Guanli Zhongxin | China, Ningbo, Zhejiang |
| Nisshinbo Holdings | Japan, Tokyo |
| Pathfinder Venture Capital Funds | Minneapolis, Minnesota, United States |
| Reflect Ventures | - |
| Rider Global | Cyprus, Limassol, Limassol |
| SG Hiscock | - |
| T2 Venture Creation | California, Portola Valley, United States |
| TechGains Funds | - |
| Tekla Capital Management | Boston, Massachusetts, United States |
| Teknologisk Innovation AS | Denmark, Hovedstaden, Tåstrup |
| Ziff Davis | New York, New York, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
VerImmune | $3M | 20 Sep 2023 | Baltimore, Maryland, United States | ||
Bianjie.AI | 14 Sep 2023 | Shanghai, Shanghai, China | |||
Scolioscan | $5M | 18 May 2023 | New Territories, Hong Kong, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China | ||
Zurimed Technologies | $7M | 04 Jul 2022 | Zürich, Zurich, Switzerland | ||
UniXell | $30M | 14 Mar 2022 | Shanghai, Shanghai, China | ||
Jianjia Robot | 20 May 2021 | Hangzhou, Zhejiang, China | |||
Gyroscope Therapeutics | $147M | 26 Mar 2021 | United Kingdom, England, United Kingdom | ||
| $40M | 31 Jul 2019 | Qingyang District, Sichuan, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
VerImmune | $3M | 20 Sep 2023 | Baltimore, Maryland, United States | ||
Bianjie.AI | 14 Sep 2023 | Shanghai, Shanghai, China | |||
Scolioscan | $5M | 18 May 2023 | New Territories, Hong Kong, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China | ||
Zurimed Technologies | $7M | 04 Jul 2022 | Zürich, Zurich, Switzerland | ||
UniXell | $30M | 14 Mar 2022 | Shanghai, Shanghai, China | ||
Jianjia Robot | 20 May 2021 | Hangzhou, Zhejiang, China | |||
Gyroscope Therapeutics | $147M | 26 Mar 2021 | United Kingdom, England, United Kingdom | ||
| $40M | 31 Jul 2019 | Qingyang District, Sichuan, China |
